Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections

被引:40
|
作者
Ambrosioni, Juan [1 ,2 ]
Junier, Thomas [3 ,4 ]
Delhumeau, Cecile [2 ]
Calmy, Alexandra [2 ]
Hirschel, Bernard [2 ]
Zdobnov, Evgeny [3 ,4 ]
Kaiser, Laurent [1 ]
Yerly, Sabine [1 ]
机构
[1] Univ Hosp, Virol Lab, Dept Genet & Lab Med, Geneva, Switzerland
[2] Univ Hosp, Div Infect Dis, HIV Unit, Dept Med Special, Geneva, Switzerland
[3] Univ Hosp Geneva, Computat Evolutionary Genom Grp, CH-1211 Geneva 14, Switzerland
[4] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland
基金
瑞士国家科学基金会;
关键词
HIV transmission; MSM; molecular epidemiology highly active antiretroviral therapy; prevention; recent infection; resistance; DRUG-RESISTANCE; TRANSMISSION CLUSTERS; SUBTYPE B; INTERRUPTION; PREVENTION; MUTATIONS;
D O I
10.1097/QAD.0b013e32835805b6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To evaluate HIV-1 transmission trends and the impact of highly active anti-retroviral therapy (HAART) on newly diagnosed HIV infections in Geneva, Switzerland. Design: Retrospective molecular epidemiology analysis of all newly HIV-diagnosed individuals between 2008 and 2010. Methods: Phylogenetic analyses were performed using pol sequences of 780 newly HIV-1 diagnosed individuals between 2000 and 2010 (mandatory reporting) and 1058 individuals diagnosed before 2000. All clusters (bootstrap value >98%) including individuals diagnosed in 2008-2010 were analyzed. Recent HIV infections (<1 year) were determined by documented seroconversion and/or fraction of ambiguous nucleotides. Median viral load and HAART coverage during the study period were obtained from patients included in the Swiss HIV Cohort Study (SHCS). Results: Among 142 newly diagnosed individuals during 2008-2010, 49% had a recent infection and 42% were included in transmission clusters. Among the latter, two-thirds were included in new clusters and one-third expanded previously known clusters. MSM carrying resistant strains were more frequently included in clusters. Only 1.8% of individuals diagnosed before 2000 and 10.8% diagnosed during 2000-2008 were included in clusters involving individuals diagnosed between 2008 and 2010. During 2008-2010, the median population viral load of SHCS-enrolled individuals was significantly lower for individuals diagnosed before 2000 than for those diagnosed during 2000-2008 and 2008-2010 and HAART coverage significantly higher. Conclusions: MSM with recent HIV infection are a significant source of onward transmission. Individuals diagnosed before 2000 were only exceptionally related to newly diagnosed infections between 2008 and 2010. Prevention campaigns need to be focused on improving diagnosis for recently infected individuals. (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:2079 / 2086
页数:8
相关论文
共 50 条
  • [1] Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy
    Fang, C. T.
    Chang, Y. Y.
    Hsu, H. M.
    Twu, S. J.
    Chen, K. T.
    Lin, C. C.
    Huang, L. Y. L.
    Chen, M. Y.
    Hwang, J. S.
    Wang, J. D.
    Chuang, C. Y.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2007, 100 (02) : 97 - 105
  • [3] Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia
    O'Bryan T.A.
    Okulicz J.F.
    Bradley W.P.
    Ganesan A.
    Wang X.
    Agan B.K.
    [J]. BMC Research Notes, 8 (1)
  • [4] Transmission network structure and newly diagnosed HIV infections: a molecular epidemiology study
    Kwan, Tsz Ho
    Wong, Ngai Sze
    Chan, Kenny Chi Wai
    Tsang, Owen Tak Yin
    Lee, Man Po
    Lui, Grace Chung Yan
    Chan, Denise Pui Chung
    Yam, Wing Cheong
    Lee, Shui Shan
    [J]. LANCET, 2017, 390 : S71 - S71
  • [5] Impact of highly active and antiretroviral therapy (HAART) on opportunistic infections
    Currier, J
    [J]. INFECTIONS IN MEDICINE, 1997, 14 : 29 - 30
  • [6] HIV infections and nutritional status during highly active antiretroviral therapy
    Spacone, A
    Ricci, F
    Falasca, K
    Ceccomancini, A
    Dalessandro, M
    Pizzigallo, E
    [J]. TWELFTH NATIONAL CONVENTION: AIDS AND RELATED SYNDROMES, 2000, : 171 - 174
  • [7] Premature labour precipitated by highly active antiretroviral therapy: an adverse reaction in a newly diagnosed HIV-positive patient
    Broom, Jennifer
    Sowden, David
    [J]. SEXUAL HEALTH, 2011, 8 (03) : 436 - 438
  • [8] HIV transmission links between past and newly diagnosed infections: a molecular epidemiology study
    Kwan, Tsz Ho
    Wong, Ngai Sze
    Lui, Grace Chung Yan
    Chan, Kenny Chi Wai
    Tsang, Owen Tak Yin
    Leung, Wai Shing
    Ho, Kai Man
    Lee, Man Po
    Lam, Wilson
    Chan, Sze Nga
    Chan, Denise Pui Chung
    To, Sabrina Wai Chi
    Yam, Wing Cheong
    Lee, Shui Shan
    [J]. LANCET, 2019, 394 : 4 - 4
  • [9] Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV-infected subjects
    Donati, KD
    Tumbarello, M
    Tacconelli, E
    Bertagnolio, S
    Rabagliati, R
    Scoppettuolo, G
    Citton, R
    Cataldo, M
    Rastrelli, E
    Fadda, G
    Cauda, R
    [J]. JOURNAL OF CHEMOTHERAPY, 2003, 15 (01) : 60 - 65
  • [10] Impact of Hepatitis B-Active Combination Antiretroviral Therapy on Hepatitis B Susceptibility in Newly Diagnosed HIV Patients
    Calisti, Giorgio
    Capocci, Santino J.
    Ware, Alexander
    Dudill, Rebecca
    Smith, Colette
    Johnson, Margaret A.
    Lipman, Marc C. I.
    Webster, Daniel P.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 58 (01) : 137 - +